| Antipsychotics, metabolic adverse effects, and cognitive function in schizophrenia NE MacKenzie, C Kowalchuk, SM Agarwal, KA Costa-Dookhan, ... Frontiers in psychiatry 9, 622, 2018 | 219 | 2018 |
| Brain insulin action in schizophrenia: Something borrowed and something new SM Agarwal, F Caravaggio, KA Costa-Dookhan, L Castellani, ... Neuropharmacology 163, 107633, 2020 | 57 | 2020 |
| The clozapine to norclozapine ratio: a narrative review of the clinical utility to minimize metabolic risk and enhance clozapine efficacy KA Costa-Dookhan, SM Agarwal, A Chintoh, VN Tran, N Stogios, ... Expert opinion on drug safety 19 (1), 43-57, 2020 | 51 | 2020 |
| Preclinical and clinical sex differences in antipsychotic-induced metabolic disturbances: a narrative review of adiposity and glucose metabolism LN Castellani, KA Costa-Dookhan, WB McIntyre, DC Wright, SA Flowers, ... Journal of psychiatry and brain science 4, e190013, 2019 | 48 | 2019 |
| Metformin for early comorbid glucose dysregulation and schizophrenia spectrum disorders: a pilot double-blind randomized clinical trial SM Agarwal, R Panda, KA Costa-Dookhan, NE MacKenzie, QC Treen, ... Translational Psychiatry 11 (1), 219, 2021 | 34 | 2021 |
| Brain insulin action: Implications for the treatment of schizophrenia SM Agarwal, C Kowalchuk, L Castellani, KA Costa-Dookhan, ... Neuropharmacology 168, 107655, 2020 | 30 | 2020 |
| Pharmacological interventions to treat antipsychotic-induced dyslipidemia in schizophrenia patients: a systematic review and meta analysis P Kanagasundaram, J Lee, F Prasad, KA Costa-Dookhan, L Hamel, ... Frontiers in psychiatry 12, 642403, 2021 | 29 | 2021 |
| Evaluating recovery colleges: a co-created scoping review E Lin, H Harris, G Black, G Bellissimo, A Di Giandomenico, T Rodak, ... Journal of Mental Health 32 (4), 813-834, 2023 | 21 | 2023 |
| Associations between plasma clozapine/N-desmethylclozapine ratio, insulin resistance and cognitive performance in patients with co-morbid obesity and ultra … KA Costa-Dookhan, TK Rajji, VN Tran, S Bowden, DJ Mueller, ... Scientific reports 11 (1), 2004, 2021 | 13 | 2021 |
| Developing an evaluation framework for assessing the impact of recovery colleges: protocol for a participatory stakeholder engagement process and cocreated scoping review E Lin, H Harris, S Gruszecki, KA Costa-Dookhan, T Rodak, ... BMJ open 12 (3), e055289, 2022 | 10 | 2022 |
| Psychosocial predictors of response to telephone-based cognitive behavioural therapy in bariatric surgery patients KA Costa-Dookhan, SE Leung, SE Cassin, S Sockalingam Canadian Journal of Diabetes 44 (3), 236-240, 2020 | 7 | 2020 |
| Antipsychotics, metabolic adverse effects, and cognitive function in schizophrenia. Front Psychiatry 9: 622 NE MacKenzie, C Kowalchuk, SM Agarwal, KA Costa-Dookhan, ... | 5 | 2018 |
| Metabolomic signatures associated with weight gain and psychosis spectrum diagnoses: a pilot study J Lee, K Costa-Dookhan, K Panganiban, N MacKenzie, QC Treen, ... Frontiers in Psychiatry 14, 1169787, 2023 | 4 | 2023 |
| Twelve tips for Natural Language Processing in medical education program evaluation KA Costa-Dookhan, MM Maslej, K Donner, F Islam, S Sockalingam, ... Medical Teacher 46 (9), 1147-1151, 2024 | 2 | 2024 |
| First episode psychosis: the commensal gut microbiota perspective. S Bowden, KA Costa-Dookhan, D Leavitt, SM Agarwal, M Hahn University of Toronto Medical Journal 97 (3), 2020 | 1 | 2020 |
| Applications of Artificial Intelligence for Non–Psychomotor Skills Training in Health Professions Education: A Scoping Review KA Costa-Dookhan, Z Adirim, M Maslej, K Donner, T Rodak, S Soklaridis, ... Academic Medicine, 10.1097, 2024 | | 2024 |
| 13. Metabolomic Signatures Associated With Weight Gain and Psychosis Spectrum Diagnoses J Lee, K Costa-Dookhan, N MacKenzie, QC Treen, A Chintoh, ... Biological Psychiatry 93 (9), S99, 2023 | | 2023 |
| Metabolomic Signatures Associated With Antipsychotic-Induced Weight Gain and Psychosis Spectrum Diagnoses J Lee, K Costa-Dookhan, A Chintoh, G Remington, D Mueller, ... NEUROPSYCHOPHARMACOLOGY 47, 378-378, 2022 | | 2022 |
| S89. INVESTIGATING METABOLIC DYSFUNCTION AND METABOLOMIC PROFILE CHANGES IN ANTIPSYCHOTIC NAIVE PATIENTS K Costa-Dookhan, SM Agarwal, A Chintoh, N Mackenzie, ... Schizophrenia Bulletin 46 (Suppl 1), S68, 2020 | | 2020 |
| Metformin for Early Onset Comorbid Type 2 Diabetes or Prediabetes in Schizophrenia Spectrum Disorders: A Double-Blind Randomized Pilot Study M Hahn, SM Agarwal, K Costa-Dookhan, P Roshni, MK Nicole, ... Biological Psychiatry 87 (9), S414, 2020 | | 2020 |
